Hauptman-Woodward Medical Research Institute and Kemp Proteins Enter Strategic Partnership for offering “Gene to Structure” solutions – Kemp Proteins

20 February 2024, Frederick, Maryland, — Kemp Proteins LLC, a leading provider of gene-to-protein and monoclonal antibody development services, today announced that the company has entered into a Strategic Partnership with Hauptman-Woodward Medical Research Institute (HWMRI). With a rich history in protein structural biology, HWMRI uses its experience and developments to characterize protein structure to better understand their biological function and the potential solutions for treating cancers, infectious disease, and metabolic disorders. The agreement demonstrates Kemp’s commitment to building a broad complement of bioservices focused on providing biopharmaceutical and diagnostic clients with world-class protein related development services and proteins as tools in drug development.

Source: Hauptman-Woodward Medical Research Institute and Kemp Proteins Enter Strategic Partnership for offering “Gene to Structure” solutions – Kemp Proteins

Advertise With Biotech Networks

Be the first to comment

Leave a Reply

Your email address will not be published.


*